Sean Arthur MacDonald - 29 May 2025 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
Director
Signature
/s/ Peter J. Weiler, Attorney-in-Fact for Sean Arthur MacDonald
Issuer symbol
EDSA
Transactions as of
29 May 2025
Net transactions value
$0
Form type
4
Filing time
02 Jun 2025, 21:19:57 UTC
Previous filing
24 Jul 2023
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MacDonald Sean Arthur Director C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA /s/ Peter J. Weiler, Attorney-in-Fact for Sean Arthur MacDonald 02 Jun 2025 0001778981

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award $0 +20,001 +974% $0.000000 22,054 29 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
F2 Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.

Remarks:

Exhibit 24 - Power of Attorney